ArticleHistopathology2018
KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.
Mitra Mehrad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papertrialcites it
ArticleHistopathology2018
Mitra Mehrad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.